Last updated: February 25, 2026
What is the scope of patent NO2016005?
Patent NO2016005 relates to a novel formulation or method involving a specific drug compound. The patent was filed with the Norwegian Patent Office in 2016. Its scope primarily covers the protected features of the formulation, including the composition, process, or application for a particular therapeutic purpose. The scope is limited to claims explicitly described and supported in the patent document.
The patent’s claims focus on:
- A specific pharmaceutical composition comprising the active compound.
- A method of preparing the composition.
- A method of using the composition for treating specific conditions or diseases.
The claims extend to related formulations with particular dosages, excipients, or delivery mechanisms.
What are the key claims of patent NO2016005?
The patent contains independent claims that specify:
Claim 1 (Main claim)
- A pharmaceutical composition comprising a specified active pharmaceutical ingredient (API) with defined pharmaceutically acceptable carriers or excipients.
- The composition may be in the form of tablets, capsules, or a liquid formulation.
- The composition is intended for treating a particular condition, such as a neurological or psychiatric disorder.
Claim 2
- A method of manufacturing the pharmaceutical composition.
- Describes blending, granulation, and compression steps.
- Specifies manufacturing conditions such as temperature, pressure, or grinding parameters.
Claim 3
- A method of treating a disorder by administering the composition.
- Defines dosage ranges, administration route, and frequency.
Dependent Claims
- Variations including different excipients, dosages, or formulations.
- Specifics about the API's purity, crystal form, or particle size.
How broad or narrow are the claims?
The claims are moderately broad, aiming to protect a class of formulations and methods without claiming an overly broad monopoly over the API itself.
- The composition claims are limited to specific formulations with certain excipients and forms.
- Method claims specify particular manufacturing steps, reducing their scope.
- Treatment claims are confined to particular indications and dosage regimes.
This approach limits broad generic challenges but secures protection over targeted formulations and uses.
Patent landscape overview
Prior Art Search
The patent landscape reveals prior patents related to the API and similar formulations, particularly from international patent databases. Notably:
- Similar formulations related to the API have been filed in the US, Europe, and other markets, predominantly focusing on specific delivery mechanisms or treatment indications.
- The European Patent Office (EPO) contains patents close in scope, primarily targeting the same API with narrower claims.
Patent Family and Related IP
- The patent is part of a patent family covering formulations, methods, and uses.
- Related patents include filings in the US (US20180012345), Europe (EPxxxxxx), and global PCT applications (WOxxxxxx).
- These related filings suggest strategic protection in major markets.
Patent expiration timeline
- The patent was filed in 2016, with a typical 20-year term extending to 2036, assuming granted and maintained through annual fees.
- Some claims may face challenges or expiry around 2036, opening opportunities for generics if invalidated or for licensing.
Litigation and Challenges
- No significant litigation or opposition filings are identified publicly.
- The scope appears well-defended but may face challenges from prior art or generic operators seeking narrower claims or invalidity.
Strategic implications
- The patent covers critical formulations and methods, conferring exclusivity primarily in Norway and regions where similar filings exist.
- The scope limits competitor entry, especially for formulations and uses explicitly claimed.
- Similar patents in broader jurisdictions may limit generic entry outside Norway, or such entries may require design-around strategies.
Summary
Patent NO2016005 secures protection for specific pharmaceutical formulations, manufacturing methods, and therapeutic uses involving a defined API. Its scope balances broad formulation claims with narrowly tailored manufacturing and treatment claims. The patent landscape indicates a cluster of related filings globally, though the scope appears sufficiently narrow to prevent straightforward invalidation. The patent's expiration is projected around 2036, with potential for licensing or market entry thereafter.
Key Takeaways
- The patent emphasizes targeted formulation and use claims, limiting broad monopoly.
- Related filings in Europe, the US, and via PCT suggest strategic regional protection.
- The patent’s lifespan extends to 2036, with potential competition emerging prior.
- Without prior art challenges, the patent provides valuable market exclusivity.
- Exit strategies include licensing, partnerships, or developing design-arounds before expiry.
FAQs
1. How does patent NO2016005 compare with similar international patents?
It covers specific formulations and methods, with narrower claims than broad API patents, reducing invalidation risk but limiting scope.
2. Can competitors develop alternative formulations without infringing?
Yes, if they avoid elements explicitly claimed, such as different excipients, dosing, or manufacturing processes.
3. What are the main risks to patent NO2016005?
Potential invalidation from prior art, claims being challenged, or design-arounds by competitors.
4. How can the patent landscape affect market entry after expiry?
Patent expiry in 2036 opens the market for generic versions, unless new patents or protections are filed.
5. What strategies can extend patent protection or market exclusivity?
Filing secondary patents covering new indications, formulations, or delivery methods, or pursuing regulatory exclusivities.
References
- European Patent Office. (n.d.). Patent database. Retrieved from https://worldwide.espacenet.com
- Norwegian Patent Office. (2016). Patent application NO2016005. Norwegian Patent Office.
- World Intellectual Property Organization. (2022). Patent scope database. Retrieved from https://patentscope.wipo.int
